<html>
<head>PUBMED IDs for BCL6B</head>
<body bgcolor='#C5F0F2'><h1>BCL6B</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10965127/'>Assignment of B-cell lymphoma 6, member B (zinc finger protein) gene (BCL6B) to human chromosome 17p13.1 by in situ hybridization.</a> August 31  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/21917650/'>Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.</a> October 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24191714/'>Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer.</a> July 11  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24560784/'>Transcriptional control of spermatogonial maintenance and differentiation.</a> January 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25008234/'>The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.</a> February 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25218345/'>B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice.</a> March 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25909168/'>Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.</a> March 2  2015<br></body></html>
